<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱(chēng)

ARN 509 - Apalutamide | JNJ-56021927

產(chǎn)品貨號(hào)

Axon 1979 CAS [956104-40-8] MF C21H15F4N5O2SMW 477.43 Purity: 99% Soluble in DMSO Description A competitive and potent antagonist of androgen receptor (AR); a promising therapeutic in both castration-sensitive and castration-resistant forms of prostate cancer (CSPC & CRPC). KEYWORDS: ARN 509 | supplier | Androgen antagonist | Apalutamide | JNJ-56021927 | ARN509 | ARN-509 | JNJ56021927 | JNJ 56021927 | CAS [956104-40-8] | Androgenic Hormones | Androgen (AR) | Antagonist | Receptors

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

ARN 509 - Apalutamide | JNJ-56021927

Based on 18 reference(s) in Google Scholar 9 10 18

Axon 1979

CAS [956104-40-8]

MF C21H15F4N5O2S
MW 477.43

Purity: 99%
Soluble in DMSO

ARN 509

Description

A competitive and potent antagonist of androgen receptor (AR); a promising therapeutic in both castration-sensitive and castration-resistant forms of prostate cancer (CSPC & CRPC).

KEYWORDS: ARN 509 | supplier | Androgen antagonist | Apalutamide | JNJ-56021927 | ARN509 | ARN-509 | JNJ56021927 | JNJ 56021927 | CAS [956104-40-8] | Androgenic Hormones | Androgen (AR) | Antagonist | Receptors

NJ Clegg et al. ARN-509: a novel anti-androgen for prostate cancer treatment. Cancer Res. 2012, 72(6), 1494-1503.?

Certificate of Analysis
Material Safety Data Sheet

Cell Signaling & Oncology Endocrinology Androgen (AR) NR3C

Antagonist of androgen receptor (AR)

Chemical name

4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide

Parent CAS No.

[956104-40-8]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>